Girl with rare tumor accepted for experimental treatment in Italy and family mobilizes to raise over R$ 1 million: 'Race for Life'
A Brazilian family is urgently trying to raise over R$ 1 million for experimental treatment in Italy for their 6-year-old daughter diagnosed with a rare and aggressive brain tumor.
6-year-old girl diagnosed with rare tumor and family seeks experimental treatment in Italy
The family of six-year-old Ana from Santarém, Brazil, is urgently seeking experimental treatment in Italy after she was diagnosed with a rare and aggressive brain tumor.
The first to receive polylaminin in MG, woman says the medication is 'a sign of hope'
A woman from Governador Valadares, Brazil, became the first in Minas Gerais to receive an experimental treatment aimed at regenerating nerve connections after a spinal cord injury.
Patient who lost movement receives treatment with polylaminin in Salvador: 'Rekindled my faith'
A 38-year-old logistics operator in Salvador receives an experimental treatment for spinal cord injury using polylaminin at a private hospital, marking a significant step in medical research in Brazil.
Ethics Committee of HC-USP denies experimental use of polylaminin on sergeant who was shot and injured spinal cord
The Medical Ethics Committee at the Hospital das Clínicas, USP, denied the request for experimental treatment with polylaminin for a police sergeant who suffered a severe spinal cord injury.
Tatiana Sampaio, researcher of polylaminin, will be honored by Alerj
Tatiana Sampaio, a researcher from UFRJ, will receive the Benemérita title from the State of Rio de Janeiro for her work on polylaminin, an experimental substance for spinal cord injury treatment.
'I want to be like before,' says the 1st young person from MT to receive polylaminin in experimental study
'I want to be like before,' says a 21-year-old from Rondonópolis, Brazil who is the first in his state to participate in an experimental treatment for spinal cord injuries using polylaminin.
Decides to give seriously ill better access to experimental medicines. – It gives hope
Norway's health committee supports granting patients with serious illnesses better access to experimental medications, providing hope for those with limited treatment options.
New oral GLP-1 reduces more glucose and weight than semaglutide in phase 3 study; Orforgliprona increases weight loss by 73%
The experimental drug orforgliprona demonstrated greater glucose control and weight loss compared to oral semaglutide in a phase 3 study for type 2 diabetes treatment.
Polylaminin: Tetraplegic athlete from Paraná applies compound that 'trended' with positive motor recovery results
A tetraplegic athlete in Brazil has seen positive results from an experimental treatment using polylaminin, a compound derived from a protein produced in the human body.
This is Fantastic: the advances in experimental treatments with polylaminin
The article discusses promising advancements in experimental treatments involving polylaminin, a placenta-derived protein that may restore movement in patients with severe spinal cord injuries.
Polylaminin: student from Balsas is the second patient in MA to receive the substance
Hector Lucena, a 26-year-old agriculture student from Balsas, became the second person in Maranhão to receive polylaminin during an experimental procedure on November 21.
Daily recap #1868: Argentina's Chamber approves labor reform, which returns to the Senate; US Supreme Court decides on legality of Trump's tariff; The steps of experimental treatment with polylaminin
Argentina's Chamber of Deputies has approved a labor reform which now goes back to the Senate, while the US Supreme Court is set to rule on Trump's tariff legality, and a patient has regained ability to walk thanks to a new treatment with polylaminin.
First maranhense to receive polylaminin, shot PM shows improvement
Military police officer Romildo Leobino is showing signs of improvement after undergoing an experimental treatment with polylaminin following his injury during an operation.
Polylaminin: student shot inside school in PI cannot participate in innovative treatment
João Lucas Campelo, a 17-year-old student who became quadriplegic after being shot, is unable to undergo an experimental polylaminin treatment due to his health condition and other constraints.
Cellular Implant Against Parkinson's Tested on Humans
Researchers at USC's Keck Medicine Medical Center are testing an experimental stem cell implant on Parkinson's patients to restore dopamine production in the brain.
Youngest patient in the country to receive polylaminin reports movement in his hands: 'I couldn't move before'
Luiz Otávio Santos Nunez, the youngest patient in Brazil to receive polylaminin, reports regaining some movement in his fingers following the experimental treatment after a serious injury.
Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries
The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.
Crans-Montana Fire: Burn Victims Will Be Treated Thanks to This Marine Worm
French researchers have developed a gel containing a molecule from a marine worm that promotes healing, which will soon be used to treat burn victims from the tragic fire in Crans-Montana.
Could there be a link between glucose levels in the brain and Alzheimer’s disease?
A Chinese study found that mice with late-stage Alzheimer's symptoms showed memory improvement and reduced brain plaque after receiving an experimental treatment targeting glucose levels in the brain.
The pastry chef who patented a molecule against cancer that has sold for 7 billion euros
Eduard Batlle, raised in his parents' bakery, is one of the inventors of petosemtamab, a groundbreaking experimental treatment for tumors that has achieved significant financial success.